The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Features of familiality in a cohort of patients (pts) with sarcoma.
Georgios Lypas
No relevant relationships to disclose
Elizabeth J. Root
No relevant relationships to disclose
Suzanne George
No relevant relationships to disclose
Andrew J. Wagner
No relevant relationships to disclose
James E. Butrynski
No relevant relationships to disclose
Jeffrey A. Morgan
No relevant relationships to disclose
George D. Demetri
Research Funding - Amgen; ARIAD; ArQule; Bristol-Myers Squibb; Daiichi Sankyo; GlaxoSmithKline; Infinity; Johnson & Johnson; Merck; Novartis; Pfizer; Roche/Genentech; Sanofi ; ZIOPHARM Oncology
Lisa DiGianni
No relevant relationships to disclose
Serena Masciari
No relevant relationships to disclose
Michelle Genevieve Rath
No relevant relationships to disclose
Judy Ellen Garber
No relevant relationships to disclose
Chandrajit P. Raut
No relevant relationships to disclose